Necroptosis inhibitors: mechanisms of action and therapeutic potential.

Zhou, Yingbo; Cai, Zhangtao; Zhai, Yijia; Yu, Jintao; He, Qiujing; He, Yuan; Jitkaew, Siriporn; Cai, Zhenyu

Zhou, Yingbo; Cai, Zhangtao; Zhai, Yijia; Yu, Jintao; He, Qiujing; He, Yuan; Jitkaew, Siriporn; Cai, Zhenyu.

Afiliación

Zhou Y; School of Medicine, Tongji University, Shanghai, 200092, China.
Cai Z; School of Medicine, Tongji University, Shanghai, 200092, China.
Zhai Y; School of Medicine, Tongji University, Shanghai, 200092, China.
Yu J; School of Medicine, Tongji University, Shanghai, 200092, China.
He Q; School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
He Y; Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Jitkaew S; Center of Excellence for Cancer and Inflammation, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Cai Z; School of Medicine, Tongji University, Shanghai, 200092, China. drcaizhenyu@tongji.edu.cn.

Apoptosis ; 29(1-2): 22-44, 2024 Feb.

Article en En | MEDLINE | ID: mdl-38001341

Asunto(s)

Apoptosis; Proteínas Quinasas; Humanos; Proteínas Quinasas/genética; Proteínas Quinasas/metabolismo; Necroptosis/genética; Muerte Celular; Necrosis/genética; Proteína Serina-Treonina Quinasas de Interacción con Receptores/metabolismo

Palabras clave

Inhibitors; MLKL; Necroptosis; RIPK1; RIPK3

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Quinasas / Apoptosis Límite: Humans Idioma: En Revista: Apoptosis Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google